These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 7887975
1. Transcriptional and post-transcriptional analysis of peroxisomal protein encoding genes from rat treated with an hypolipemic agent, ciprofibrate. Effect of an intermittent treatment and influence of obesity. Caira F, Pacot C, Bardot O, Cherkaoui Malki M, Latruffe N. Biochem Pharmacol; 1995 Mar 01; 49(5):611-9. PubMed ID: 7887975 [Abstract] [Full Text] [Related]
2. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T, Hashimoto T, Lalwani ND. Proc Natl Acad Sci U S A; 1986 Mar 01; 83(6):1747-51. PubMed ID: 3456610 [Abstract] [Full Text] [Related]
3. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Intrasuksri U, Rangwala SM, O'Brien M, Noonan DJ, Feller DR. Gen Pharmacol; 1998 Aug 01; 31(2):187-97. PubMed ID: 9688458 [Abstract] [Full Text] [Related]
5. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate. Pacot C, Petit M, Rollin M, Behechti N, Moisant M, Deslex P, Althoff J, Lhuguenot JC, Latruffe N. Arch Biochem Biophys; 1996 Mar 01; 327(1):181-8. PubMed ID: 8615689 [Abstract] [Full Text] [Related]
10. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Chu R, Madison LD, Lin Y, Kopp P, Rao MS, Jameson JL, Reddy JK. Proc Natl Acad Sci U S A; 1995 Dec 05; 92(25):11593-7. PubMed ID: 8524810 [Abstract] [Full Text] [Related]
11. Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity as compared to Zucker lean and Sprague-Dawley rats. Pacot C, Petit M, Caira F, Rollin M, Behechti N, Grégoire S, Cherkaoui Malki M, Cavatz C, Moisant M, Moreau C. Biol Cell; 1993 Dec 05; 77(1):27-35. PubMed ID: 8518742 [Abstract] [Full Text] [Related]
13. Role of thyroid state on induction by ciprofibrate of laurate hydroxylase and peroxisomal enzymes in rat liver microsomes. Pacot C, Charmoillaux M, Goudonnet H, Truchot RC, Latruffe N. Biochem Pharmacol; 1993 Apr 06; 45(7):1437-46. PubMed ID: 8471068 [Abstract] [Full Text] [Related]
14. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ, Winham MA, Old SL, Gray TJ. Xenobiotica; 1996 Jul 06; 26(7):695-707. PubMed ID: 8819300 [Abstract] [Full Text] [Related]
15. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Wilson MW, Lay LT, Chow CK, Tai HH, Robertson LW, Glauert HP. Arch Toxicol; 1995 Jul 06; 69(7):491-7. PubMed ID: 8526745 [Abstract] [Full Text] [Related]
16. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Chen H, Huang CY, Wilson MW, Lay LT, Robertson LW, Chow CK, Glauert HP. Carcinogenesis; 1994 Dec 06; 15(12):2847-50. PubMed ID: 8001245 [Abstract] [Full Text] [Related]